AzTrials
AzTrials

Oxygen ConsumptionMCCS-CCPETSNCT07108296

A Study on Cardiopulmonary Exercise Tolerance Standards for Healthy Chinese Population

An observational study of Oxygen Consumption and Cardiorespiratory Fitness, run by Affiliated Hospital of Changchun University of Chinese Medicine at 15 sites in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This project intends to conduct a large-sample, prospective, multicenter clinical cohort study in healthy populations. By utilizing a digital cardiopulmonary rehabilitation clinical data research platform, The investigators aim to achieve automated, standardized, and uniform collection, analysis, and AI modeling of… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Oxygen Consumption, Cardiorespiratory Fitness
What is being tested?
cardiopulmonary exercise testing (CPET)
How many people
4,620 participants
Where
15 sitesChina
Study dates
1 Sep 2025to 30 Mar 2027
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy individuals aged 18 - 65.

Who may be able to join

  • Detailed medical history taken, with no symptoms of discomfort reported
  • Good physical condition, with no history of severe chronic diseases
  • No history of long - term medication use
  • Willing to undergo cardiopulmonary exercise testing, with no ST - T segment changes observed during the test
  • Age: 18 - 65 years old
  • BMI: 18.5 - 28kg/m²
  • No smoking history or quit smoking for ≥5 years
  • Physical examination reports within 2 years show no significant abnormalities.

Who cannot join

  • Pre - test resting blood pressure ≥160/100 mmHg (1 mmHg=0.133 kPa)
  • Chronic cardiovascular diseases, such as heart failure, coronary atherosclerotic heart disease, hypertension, congenital heart disease, cardiomyopathy, and severe arrhythmias
  • Respiratory diseases, such as chronic obstructive pulmonary disease, asthma, pulmonary artery hypertension, bronchiectasis, and respiratory failure
  • Digestive system diseases, such as peptic ulcer, gastrointestinal bleeding, hepatitis, liver cirrhosis, ulcerative colitis, Crohn's disease, chronic pancreatitis, and chronic cholecystitis
  • Endocrine system diseases, such as hyperthyroidism, hypothyroidism, diabetes, and other diseases with clear hormone abnormalities
  • Acute or chronic kidney diseases, blood system diseases, malignant tumors, and bone and joint diseases that affect activity
Show all 9Show fewer
  • No history of acute infection within 2 weeks
  • Unable to cooperate with the examination
  • Contraindications to cardiopulmonary exercise testing: acute myocardial infarction

Trial locations and contacts

15 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Head of Cardiac Rehabilitation Department contact

+86 131 8088 9430

Xiopingmeng@126.com

15 sites in 1 country

China15 sites
  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100730

    Rongjing R Ding, MD, +86 13552548612

  • Affiliated Hospital of Changchun University of Chinese Medicine

    Changchun, Jilin, 130000

    Head of Cardiac Rehabilitation Department, +86 131 8088 9430, Xiopingmeng@126.com

  • Xiangya Second Hospital of Central South University

    Changsha, Hunan, 410011

    Danyan D Xu, MD, +86 13974874636

  • Daqing Oilfield General Hospital

    Daqing, Heilongjiang, 163000

    Zhiqing Z Fan, MD, +86 13836769588

  • Guangdong Provincial People's Hospital Affiliated to Southern Medical University

    Guangzhou, Guangdong, 510080

    Huan H Ma, MD, +86 15018755932

  • Guangdong Provincial Hospital of Chinese Medicine

    Guangzhou, Guangdong, 510120

    Wei W Jiang, MD, +86 15630050688

  • The Second Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150086

    Jian J Wu, MD, +86 15245001123

  • Qilu Hospital of Shandong University

    Jinan, Shangdong, 250012

    Lin L Shen, MD, +86 18560082257

  • Jiangbin Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, 530021

    Youcai Y Hu, MD, +86 13978870585

  • Anyang Regional Hospital of Puyang City, Henan Province

    Puyang, Henan, 457000

    Hui H Liu, MD, +86 13903727688

  • Quanzhou First Hospital Affiliated to Fujian Medical University

    Quanzhou, Fujian, 362000

    Ruozhu R Dai, +86 18960337219

  • Tongji Hospital

    Shanghai, Shanghai Municipality, 200065

    Head of Cardiac Rehabilitation Department, +86 13661615008

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030

    Cuntai C Zhang, MD, +86 15927668408

  • First Affiliated Hospital of Xi'an Jiaotong University

    Xi’an, Shanxi, 710061

    Fenling F Fan, MD, +86 15182916660

  • Zhengzhou Central Hospital Affiliated to Zhengzhou University

    Zhengzhou, Henan, 450000

    Dongwei D Wang, +86 18937633428

Other trials in China

About this study

Official title: Multi-center Clinical Cohort Study on Cardiopulmonary Exercise Tolerance Standards in Chinese Healthy Population

This project intends to conduct a large-sample, prospective, multicenter clinical cohort study in healthy populations. By utilizing a digital cardiopulmonary rehabilitation clinical data research platform, The investigators aim to achieve automated, standardized, and uniform collection, analysis, and AI modeling of large-scale cardiopulmonary exercise testing (CPET) data. The ultimate goals are:

To establish reference standards for cardiopulmonary exercise capacity in the Chinese healthy population.

Read more

To develop machine learning-based predictive models for key CPET variables (e.g., peak VO₂) tailored to Chinese demographics.

To compare performance differences between domestically produced and imported CPET devices.

Being tested
cardiopulmonary exercise testing (CPET)
Keywords
Peak Oxygen Uptake, VO2@AT, Cardiopulmonary Exercise Tolerance, Prediction Model, Healthy Population

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cardiopulmonary exercise testing (CPET)Other

    In this study, the cardiopulmonary exercise testing (CPET) system used breath-by-breath continuous analysis for gas exchange and ventilation variables. The protocol included spirometry with an 8-breath data collection method. The cycle ergometer workload ranged from 10 to 40 W/min using a RAMP protocol. The standard CPET protocol comprised a 3-min rest, 3-min warm-up, 8 - 12 min incremental exercise phase, and 3-min each of active and passive recovery.

Study groups in NCT07108296
Study groupRoleWhat they receive
Chinese Age-Sex-Stratified Cardiopulmonary Function Cohort (CACSF Cohort)Not described
Receives: Other: cardiopulmonary exercise testing (CPET)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak Oxygen Uptake

    When measuring the peak oxygen uptake of healthy people with a cycle ergometer, first ensure participants are healthy and have signed consent forms. Prepare the cycle ergometer and other equipment, adjusting them to a suitable position. After a 3 - minute warm - up, start the incremental loading test, which lasts 8 - 12 minutes, until termination criteria are met. Record the data, calculate the peak oxygen uptake, and assess the cardiopulmonary function.

    Measured: On the day of enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
4,620 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07108296
Sponsor's protocol ID
KFKT-2025-KY-010
Other IDs
KFKT-2025-KY-010
Acronym
MCCS-CCPETS
Status last verified
Aug 2025
First submitted
4 Aug 2025
Last updated
11 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: all IPD collected throughout the trial, only IPD used in the results publication

Publications

  • Strain T, Flaxman S, Guthold R, Semenova E, Cowan M, Riley LM, Bull FC, Stevens GA; Country Data Author Group. National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022: a pooled analysis of 507 population-based surveys with 5.7 million participants. Lancet Glob Health. 2024 Aug;12(8):e1232-e1243. doi: 10.1016/S2214-109X(24)00150-5. Epub 2024 Jun 25.

    PubMed 38942042
  • Weeldreyer NR, De Guzman JC, Paterson C, Allen JD, Gaesser GA, Angadi SS. Cardiorespiratory fitness, body mass index and mortality: a systematic review and meta-analysis. Br J Sports Med. 2025 Feb 20;59(5):339-346. doi: 10.1136/bjsports-2024-108748.

    PubMed 39537313
  • Wang J, Ren C, Xu S, Yuan Y, Song Y, Xie D, Wang K, Yuan L, Shen T, Xu L, Tang Y, Gao W, Zhao W. A reference equation for peak oxygen uptake for cycle ergometry in Chinese adult participants. Sci Rep. 2025 Mar 29;15(1):10876. doi: 10.1038/s41598-025-94207-7.

    PubMed 40157952
  • Brazile TL, Levine BD, Shafer KM. Cardiopulmonary Exercise Testing. NEJM Evid. 2025 Feb;4(2):EVIDra2400390. doi: 10.1056/EVIDra2400390. Epub 2025 Jan 28.

    PubMed 39873542
  • Kokkinos P, Kaminsky LA, Arena R, Zhang J, Myers J. A new generalized cycle ergometry equation for predicting maximal oxygen uptake: The Fitness Registry and the Importance of Exercise National Database (FRIEND). Eur J Prev Cardiol. 2018 Jul;25(10):1077-1082. doi: 10.1177/2047487318772667. Epub 2018 Apr 25.

    PubMed 29692203
  • Kaminsky LA, Myers J, Arena R. Determining Cardiorespiratory Fitness With Precision: Compendium of Findings From the FRIEND Registry. Prog Cardiovasc Dis. 2019 Jan-Feb;62(1):76-82. doi: 10.1016/j.pcad.2018.10.003. Epub 2018 Oct 30.

    PubMed 30385268
  • Daneshvar F, Weinreich M, Daneshvar D, Sperling M, Salmane C, Yacoub H, Gabriels J, McGinn T, Smith MC. Cardiorespiratory Fitness in Internal Medicine Residents: Are Future Physicians Becoming Deconditioned? J Grad Med Educ. 2017 Feb;9(1):97-101. doi: 10.4300/JGME-D-15-00720.1.

    PubMed 28261402
  • de Souza E Silva CG, Kaminsky LA, Arena R, Christle JW, Araujo CGS, Lima RM, Ashley EA, Myers J. A reference equation for maximal aerobic power for treadmill and cycle ergometer exercise testing: Analysis from the FRIEND registry. Eur J Prev Cardiol. 2018 May;25(7):742-750. doi: 10.1177/2047487318763958. Epub 2018 Mar 8.

    PubMed 29517365
  • Ashikaga K, Itoh H, Maeda T, Itoh H, Ichikawa Y, Tanaka S, Ajisaka R, Koike A, Makita S, Omiya K, Kato Y, Adachi H, Nagayama M, Tajima A, Harada N, Akashi YJ; Committee on Exercise Prescription for Patients (CEPP) Members. Ventilatory efficiency during ramp exercise in relation to age and sex in a healthy Japanese population. J Cardiol. 2021 Jan;77(1):57-64. doi: 10.1016/j.jjcc.2020.07.008. Epub 2020 Aug 5.

    PubMed 32768174
  • Katzmarzyk PT, Friedenreich C, Shiroma EJ, Lee IM. Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries. Br J Sports Med. 2022 Jan;56(2):101-106. doi: 10.1136/bjsports-2020-103640. Epub 2021 Mar 29.

    PubMed 33782046

Questions about this trial

What is this clinical trial studying?

An observational study of Oxygen Consumption and Cardiorespiratory Fitness, run by Affiliated Hospital of Changchun University of Chinese Medicine at 15 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 15 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Head of Cardiac Rehabilitation Department (+86 131 8088 9430, Xiopingmeng@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak Oxygen Uptake (time frame: On the day of enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07108296, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in